Juno notches positive data for second-chance CAR-T – FierceBiotech
FierceBiotech |
Juno notches positive data for second-chance CAR–T
FierceBiotech Coming off the back of a series of trial deaths last year and the axing of its once-leading CAR-T treatment JCAR015 at the start of the year, Juno posted new data at ASCO showing some positive data for its second chance CAR-T, although a death and some … Juno Therapeutics Inc (JUNO) Presents Updated TRANSCEND … |
